SFDA Drafts New Fast Track Procedures For Drug Registration
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China regulators released a streamlined draft drug approval rule this month that would provide for faster approval of four categories of new drugs. The State Food and Drug Administration finished collecting public comments on the rule Oct. 15